Cargando…

Safety and Effectiveness of Blind Percutaneous Liver Biopsy: Analysis of 1412 Procedures

BACKGROUND: Percutaneous liver biopsy is one of the most important and widely used methods for diagnosing chronic liver diseases; however, controversies related to the potential risk of complications and patient discomfort still exist. OBJECTIVES: The objective of this study was to evaluate the safe...

Descripción completa

Detalles Bibliográficos
Autores principales: Szymczak, Aleksandra, Simon, Krzysztof, Inglot, Malgorzata, Gladysz, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298873/
https://www.ncbi.nlm.nih.gov/pubmed/22451841
_version_ 1782226051301113856
author Szymczak, Aleksandra
Simon, Krzysztof
Inglot, Malgorzata
Gladysz, Andrzej
author_facet Szymczak, Aleksandra
Simon, Krzysztof
Inglot, Malgorzata
Gladysz, Andrzej
author_sort Szymczak, Aleksandra
collection PubMed
description BACKGROUND: Percutaneous liver biopsy is one of the most important and widely used methods for diagnosing chronic liver diseases; however, controversies related to the potential risk of complications and patient discomfort still exist. OBJECTIVES: The objective of this study was to evaluate the safety and success rate of blind percutaneous liver biopsy. PATIENTS AND METHODS: We conducted a retrospective analysis of 1412 blind percutaneous thick-needle liver biopsies performed during 1977-2000 at a single center on 1110 patients, using archived medical data of the center. RESULTS: The overall success rate of obtaining a liver sample with this method was 95.3%. Of all the samples assessed, 91.7% were determined to be fully representative for an evaluation by the pathologist. Complications occurred in 259 procedures (18.3%). While no fatalities associated with liver biopsy were noted, 9 serious complications (0.64%) directly related to biopsies were reported. Pain was the most common complication (15.3%). Significantly more complications (pain and vasovagal reactions) were reported in females (22.1%) than in males (16.1%) (P = 0.005). The rate of complications was significantly correlated with the stage of fibrosis (P = 0.027), i.e. the higher the fibrosis stage, the higher the complication rate. Previous surgical procedures involving the abdominal cavity or thorax influenced the effectiveness of liver biopsy (P = 0.017). Less operator experience was significantly associated with a higher rate of procedure failure (P = 0.002). Statistical significance of the relationship between individual operator efficiency and complication rate (P = 0.000) and that between individual operator efficiency and biopsy failure rate (P = 0.002) was observed. CONCLUSIONS: Blind percutaneous liver biopsy is a safe and effective invasive procedure, despite the fact that noninvasive fibrosis assessment methods are currently widely available and used instead of histological evaluation. Complications risk and failure rate are low if indications and contraindications are considered carefully and the biopsy is performed by a skilled and experienced operator. Certain groups of patients may benefit from an image-guided procedure to improve its effectiveness.
format Online
Article
Text
id pubmed-3298873
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Kowsar
record_format MEDLINE/PubMed
spelling pubmed-32988732012-03-26 Safety and Effectiveness of Blind Percutaneous Liver Biopsy: Analysis of 1412 Procedures Szymczak, Aleksandra Simon, Krzysztof Inglot, Malgorzata Gladysz, Andrzej Hepat Mon Original Article BACKGROUND: Percutaneous liver biopsy is one of the most important and widely used methods for diagnosing chronic liver diseases; however, controversies related to the potential risk of complications and patient discomfort still exist. OBJECTIVES: The objective of this study was to evaluate the safety and success rate of blind percutaneous liver biopsy. PATIENTS AND METHODS: We conducted a retrospective analysis of 1412 blind percutaneous thick-needle liver biopsies performed during 1977-2000 at a single center on 1110 patients, using archived medical data of the center. RESULTS: The overall success rate of obtaining a liver sample with this method was 95.3%. Of all the samples assessed, 91.7% were determined to be fully representative for an evaluation by the pathologist. Complications occurred in 259 procedures (18.3%). While no fatalities associated with liver biopsy were noted, 9 serious complications (0.64%) directly related to biopsies were reported. Pain was the most common complication (15.3%). Significantly more complications (pain and vasovagal reactions) were reported in females (22.1%) than in males (16.1%) (P = 0.005). The rate of complications was significantly correlated with the stage of fibrosis (P = 0.027), i.e. the higher the fibrosis stage, the higher the complication rate. Previous surgical procedures involving the abdominal cavity or thorax influenced the effectiveness of liver biopsy (P = 0.017). Less operator experience was significantly associated with a higher rate of procedure failure (P = 0.002). Statistical significance of the relationship between individual operator efficiency and complication rate (P = 0.000) and that between individual operator efficiency and biopsy failure rate (P = 0.002) was observed. CONCLUSIONS: Blind percutaneous liver biopsy is a safe and effective invasive procedure, despite the fact that noninvasive fibrosis assessment methods are currently widely available and used instead of histological evaluation. Complications risk and failure rate are low if indications and contraindications are considered carefully and the biopsy is performed by a skilled and experienced operator. Certain groups of patients may benefit from an image-guided procedure to improve its effectiveness. Kowsar 2012-01 2012-01-20 /pmc/articles/PMC3298873/ /pubmed/22451841 Text en Copyright © 2011, Kowsar M.P. Co. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Szymczak, Aleksandra
Simon, Krzysztof
Inglot, Malgorzata
Gladysz, Andrzej
Safety and Effectiveness of Blind Percutaneous Liver Biopsy: Analysis of 1412 Procedures
title Safety and Effectiveness of Blind Percutaneous Liver Biopsy: Analysis of 1412 Procedures
title_full Safety and Effectiveness of Blind Percutaneous Liver Biopsy: Analysis of 1412 Procedures
title_fullStr Safety and Effectiveness of Blind Percutaneous Liver Biopsy: Analysis of 1412 Procedures
title_full_unstemmed Safety and Effectiveness of Blind Percutaneous Liver Biopsy: Analysis of 1412 Procedures
title_short Safety and Effectiveness of Blind Percutaneous Liver Biopsy: Analysis of 1412 Procedures
title_sort safety and effectiveness of blind percutaneous liver biopsy: analysis of 1412 procedures
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298873/
https://www.ncbi.nlm.nih.gov/pubmed/22451841
work_keys_str_mv AT szymczakaleksandra safetyandeffectivenessofblindpercutaneousliverbiopsyanalysisof1412procedures
AT simonkrzysztof safetyandeffectivenessofblindpercutaneousliverbiopsyanalysisof1412procedures
AT inglotmalgorzata safetyandeffectivenessofblindpercutaneousliverbiopsyanalysisof1412procedures
AT gladyszandrzej safetyandeffectivenessofblindpercutaneousliverbiopsyanalysisof1412procedures